A Phase I, Study of CDX-1140 a fully human agonist anti-CD40 monoclonal antibody as monotherapy or in combination in patients with advanced solid tumors
A Phase I, Study of CDX-1140 a fully human agonist anti-CD40 monoclonal antibody as monotherapy or in combination in patients with advanced solid tumors
Trial Category:
Head and Neck
Phase
I
Contact(s)
Location(s)
Nebraska Cancer Specialists, Omaha, NE
